NSEUpdates31 Jul 2026 · 31 Jul 2026, 10:11 pm
Updates
Neuland Laboratories Limited · NEULANDLAB
✦ AI SummaryExpansion
Neuland Laboratories Limited has commenced commercial production at two additional capacities under its expansion plans at its units in Telangana, India.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Neuland Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI Listing Regulations'.
Attachments (1)
📄pdf
Download →
NEULANDLAB_31072026220542_SignedSEIntimation31072026.pdf
View document text
July 31, 2026
BSE Limited The National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza,
Dalal Street, Mumbai – 400 001 Bandra Kurla Complex
Bandra (E), Mumbai – 400 001
Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ
Dear Sir/Madam,
Sub : Intimation under Regulation 30 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing
Regulations")
Ref : Our letters dated August 1, 2024 and January 21, 2025
In continuation of our letters dated August 1, 2024 and January 21, 2025 and pursuant to
Regulation 30 of the SEBI Listing Regulations, we would like to inform you that the Company has
commenced the commercial production of the additional capacities under the expansion plans
at Unit 1 situated at Bonthapally Village, Gummadidala Mandal, Sangareddy District, Telangana,
India – 502313 and Unit 3 situated at Survey No. 10, Plot No. 3-72, Gaddapotharam Village,
Jinnaram Mandal, Sangareddy District, Telangana - 502 319, respectively.
This is for your information and records.
Thanking you
Yours Sincerely,
For Neuland Laboratories Limited
Sarada Bhamidipati
Company Secretary